2 news items
SAB Biotherapeutics to Present at INNODIA Annual Meeting
SABS
8 Apr 24
on T1D; and access to a qualified community of people and families living with T1D. INNODIA Managing Director Manuela Battaglia, Ph.D, said
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results
SABS
29 Mar 24
has also been deeply involved in the type 1 diabetes community for over 20 years, including as a volunteer and member of the Young Leadership
- Prev
- 1
- Next